Pseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid Signaling
Eric Morello,Teresa Pérez-Berezo,Chloé Boisseau,Thomas Baranek,Antoine Guillon,Déborah Bréa,Philippe Lanotte,Xavier Carpena,Nicolas Pietrancosta,Virginie Hervé,Reuben Ramphal,Nicolas Cenac,Mustapha Si-Tahar
DOI: https://doi.org/10.3389/fmicb.2019.01826
IF: 5.2
2019-08-14
Frontiers in Microbiology
Abstract:<span><i>Pseudomonas aeruginosa</i> is an opportunistic bacteria and a major cause of nosocomial pneumonia. <i>P. aeruginosa</i> has many virulence factors contributing to its ability to colonize the host. LoxA is a lipoxygenase enzyme secreted by <i>P. aeruginosa</i> that oxidizes polyunsaturated fatty acids. Based on previous <i>in vitro</i> biochemical studies, several biological roles of LoxA have been hypothesized, including interference of the host lipid signaling, and modulation of bacterial invasion properties. However, the contribution of LoxA to <i>P. aeruginosa</i> lung pathogenesis <i>per se</i> remained unclear. In this study, we used complementary <i>in vitro</i> and <i>in vivo</i> approaches, clinical strains of <i>P. aeruginosa</i> as well as lipidomics technology to investigate the role of LoxA in lung infection. We found that several <i>P. aeruginosa</i> clinical isolates express LoxA. When secreted in the lungs, LoxA processes a wide range of host polyunsaturated fatty acids, which further results in the production of bioactive lipid mediators (including lipoxin A<sub>4</sub>). LoxA also inhibits the expression of major chemokines (e.g., MIPs and KC) and the recruitment of key leukocytes. Remarkably, LoxA promotes <i>P. aeruginosa</i> persistence in lungs tissues. Hence, our study suggests that LoxA-dependent interference of the host lipid pathways may contribute to <i>P. aeruginosa</i> lung pathogenesis.</span>
microbiology